CompletedNot Applicable

Relationship Between Hyperventilation Syndrome and SARS-CoV-2 Infection

France2,846 participantsStarted 2021-01-01

Plain-language summary

Following an acute COVID-19 infection, many patients suffer from long lasting physical symptoms that may greatly impair quality of life. Persisting dyspnea and other functional respiratory complaints could evoke Hyperventilation Syndrome (HVS) as a putative contributor of the long-COVID presentation in COVID-19 survivors. We aimed to assess the possible relationship between a HVS and previous acute SARS-CoV-2 infection.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Read and speak French * Perform a pulmonary function test Exclusion Criteria: \- incomplete questionnaire or inability to obtain an interpretable lung function assessment

What they're measuring

Assess the relationship between a hyperventilation syndrome and previous acute SARS-CoV-2 infection.

Timeframe: Nijmegen questionnaire during 15 minutes (cross-sectional monocentric study)

Trial details

NCT IDNCT05224830

SponsorCentral Hospital, Nancy, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-05-01

View on ClinicalTrials.gov More COVID-19 trials